Inventor

NAVE KLAUS-ARMIN

DE7 patents

⚠️ This page may combine multiple inventors who share the name “NAVE KLAUS-ARMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SYGNIS BIOSCIENCE GMBH & CO KG

3 patents

US8349619B2Jan 8, 2013

PHARNEXT

3 patents

US10940147B2Mar 9, 2021

Early treatment of CMT disease

PHARNEXT1 citations69

US10383870B2Aug 20, 2019

Early treatment of CMT disease

PHARNEXT1 citations69

US12226413B2Feb 18, 2025

Early treatment of CMT disease

PHARNEXT0 citations59

EHRENREICH HANNELORE

1 patent

US9254312B2Feb 9, 2016

Method for the treatment and/or prophylaxis of multiple sclerosis, and use of erythropoietin for the manufacture of a medicament for the intermittent treatment and/or intermittent prophylaxis of multiple sclerosis

EHRENREICH HANNELORE0 citations46

NAVE KLAUS-ARMIN

SYGNIS BIOSCIENCE GMBH & CO KG

Method for detecting and analyzing protein interactions in-vivo

Method for detecting and analyzing protein interactions in vivo

Method of treating amytrophic lateral sclerosis using melatonin

PHARNEXT

Early treatment of CMT disease

Early treatment of CMT disease

Early treatment of CMT disease

EHRENREICH HANNELORE

Method for the treatment and/or prophylaxis of multiple sclerosis, and use of erythropoietin for the manufacture of a medicament for the intermittent treatment and/or intermittent prophylaxis of multiple sclerosis